143 related articles for article (PubMed ID: 29123440)
21. Quantitative expression levels of regulated on activation, normal T cell expressed and secreted and eotaxin transcripts in toluene diisocyanate-induced allergic rats.
Im GJ; Hwang CS; Jung HH
Acta Otolaryngol; 2005 Apr; 125(4):370-7. PubMed ID: 15823807
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and onset of action of fluticasone propionate aqueous nasal spray on nasal symptoms, eosinophil count, and mediator release after nasal allergen challenge in patients with seasonal allergic rhinitis.
Wang D; Duyck F; Smitz J; Clement P
Allergy; 1998 Apr; 53(4):375-82. PubMed ID: 9574879
[TBL] [Abstract][Full Text] [Related]
23. The relationship between IL-17A and IL-22 expression and clinical severity in patients with moderate/severe persistent allergic rhinitis.
Shahsavan S; Pirayesh A; Samani OZ; Shirzad H; Zamani MA; Amani S; Kazemi SM; Moghni M; Deris F; Bageri N; Salimzadeh L; Tavakoli G; Arjenaki MG
Am J Otolaryngol; 2019; 40(2):173-178. PubMed ID: 30594402
[TBL] [Abstract][Full Text] [Related]
24. Inverse relation between nasal fluid Clara Cell Protein 16 levels and symptoms and signs of rhinitis in allergen-challenged patients with intermittent allergic rhinitis.
Benson M; Fransson M; Martinsson T; Naluai AT; Uddman R; Cardell LO
Allergy; 2007 Feb; 62(2):178-83. PubMed ID: 17298427
[TBL] [Abstract][Full Text] [Related]
25. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis.
Weido AJ; Reece LM; Alam R; Cook CK; Sim TC
Ann Allergy Asthma Immunol; 1996 Nov; 77(5):407-15. PubMed ID: 8933780
[TBL] [Abstract][Full Text] [Related]
26. A follow-up study of immunotherapy-treated birch-allergic patients: effect on the expression of chemokines in the nasal mucosa.
Plewako H; Holmberg K; Oancea I; Gotlib T; Samoliński B; Rak S
Clin Exp Allergy; 2008 Jul; 38(7):1124-31. PubMed ID: 18691293
[TBL] [Abstract][Full Text] [Related]
27. A murine model of allergic rhinitis: studies on the role of IgE in pathogenesis and analysis of the eosinophil influx elicited by allergen and eotaxin.
van de Rijn M; Mehlhop PD; Judkins A; Rothenberg ME; Luster AD; Oettgen HC
J Allergy Clin Immunol; 1998 Jul; 102(1):65-74. PubMed ID: 9679849
[TBL] [Abstract][Full Text] [Related]
28. Cytokine profiles in nasal fluid of patients with seasonal or persistent allergic rhinitis.
König K; Klemens C; Eder K; San Nicoló M; Becker S; Kramer MF; Gröger M
Allergy Asthma Clin Immunol; 2015; 11(1):26. PubMed ID: 26401140
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics.
Di Lorenzo G; Gervasi F; Drago A; Esposito Pellitteri M; Di Salvo A; Cosentino D; Potestio M; Colombo A; Candore G; Mansueto S; Caruso C
Clin Exp Allergy; 1999 Oct; 29(10):1367-77. PubMed ID: 10520057
[TBL] [Abstract][Full Text] [Related]
30. Nasal fluid release of eotaxin-3 and eotaxin-2 in persistent sinonasal eosinophilic inflammation.
De Corso E; Baroni S; Battista M; Romanello M; Penitente R; Di Nardo W; Passali GC; Sergi B; Fetoni AR; Bussu F; Zuppi C; Paludetti G
Int Forum Allergy Rhinol; 2014 Aug; 4(8):617-24. PubMed ID: 24989688
[TBL] [Abstract][Full Text] [Related]
31. The effect of fluticasone propionate aqueous nasal spray on eosinophils and cytokines in nasal secretions of patients with ragweed allergic rhinitis.
Alvarado-Valdés CA; Blomgren J; Weiler D; Gleich GJ; Reed CE; Field EA; Wisniewski ME; Pobiner BF
Clin Ther; 1997; 19(2):273-81. PubMed ID: 9152566
[TBL] [Abstract][Full Text] [Related]
32. Different levels of mucus inflammatory mediators in nasal polyposis with and without aeroallergen sensitivity.
Dimić A; Perić A; Grgurević U; Sotirović J; Labus M; Baletić N; Milojević M; Stanojević I; Vojvodić D
Laryngoscope Investig Otolaryngol; 2022 Jun; 7(3):671-678. PubMed ID: 35734071
[TBL] [Abstract][Full Text] [Related]
33. Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis.
Nathan RA; Berger W; Yang W; Cheema A; Silvey M; Wu W; Philpot E
Ann Allergy Asthma Immunol; 2008 May; 100(5):497-505. PubMed ID: 18517084
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D decreases the secretion of eotaxin and RANTES in nasal polyp fibroblasts derived from Taiwanese patients with chronic rhinosinusitis with nasal polyps.
Wang LF; Chien CY; Tai CF; Chiang FY; Chen JY
Kaohsiung J Med Sci; 2015 Feb; 31(2):63-9. PubMed ID: 25645983
[TBL] [Abstract][Full Text] [Related]
35. Subjective and objective assessments in patients with seasonal allergic rhinitis: effects of therapy with mometasone furoate nasal spray.
Meltzer EO; Jalowayski AA; Orgel HA; Harris AG
J Allergy Clin Immunol; 1998 Jul; 102(1):39-49. PubMed ID: 9679846
[TBL] [Abstract][Full Text] [Related]
36. Local expression of IL-4 and IL-5 in perennial allergic rhinitis and their modulation by topical corticosteroid therapy.
Hafez SF; Sallam MM; Ibraheem SA
Egypt J Immunol; 2004; 11(1):111-21. PubMed ID: 15724393
[TBL] [Abstract][Full Text] [Related]
37. [Chronic rhinitis--effect of topical administration of corticosteroids on eosinophilic leukocytes].
Ursulović D; Janosević L; Janosević S
Srp Arh Celok Lek; 2002; 130(7-8):243-6. PubMed ID: 12585000
[TBL] [Abstract][Full Text] [Related]
38. Effects of cryptoporus polysaccharide on rat allergic rhinitis associated with inhibiting eotaxin mRNA expression.
Xie QM; Deng JF; Deng YM; Shao CS; Zhang H; Ke CK
J Ethnopharmacol; 2006 Oct; 107(3):424-30. PubMed ID: 16765544
[TBL] [Abstract][Full Text] [Related]
39. Eotaxin but not MCP-3 induces eosinophil influx into nasal fluid in allergic patients.
Górski P; Wittczak T; Walusiak J; Pałczyński C; Ruta U; Kuna P; Alam R
Allergy; 2002 Jun; 57(6):519-28. PubMed ID: 12028117
[TBL] [Abstract][Full Text] [Related]
40. Transcription and translation of the chemokines RANTES and MCP-1 in nasal polyps and mucosa in allergic and non-allergic rhinopathies.
Marcella R; Croce A; Moretti A; Barbacane RC; Di Giocchino M; Conti P
Immunol Lett; 2003 Dec; 90(2-3):71-5. PubMed ID: 14687706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
